Related Experiment Videos

Transmyocardial laser revascularisation and other treatment modalities for angina pectoris

M Huikeshoven1, J A P van der Sloot, R Tukkie

  • 1Laser Centre, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ, The Netherlands. m.huikeshoven@amc.uva.nl

Insights

Ischaemic heart disease, a leading cause of death, includes angina pectoris. This overview covers conventional and alternative treatments, focusing on transmyocardial laser revascularisation for heart disease.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Medical Technology

Background:

  • Ischaemic heart disease is a major global health concern, contributing significantly to morbidity and mortality.
  • Angina pectoris is a common clinical manifestation of ischaemic heart disease, characterized by chest pain due to myocardial ischemia.
  • Effective management of angina pectoris is crucial for improving patient outcomes and reducing healthcare burdens.

Observation:

  • This paper reviews current therapeutic strategies for angina pectoris.
  • It encompasses established conventional treatments.
  • The review also explores emerging and alternative treatment modalities.

Findings:

  • Conventional treatments for angina pectoris include lifestyle modifications, pharmacotherapy, and revascularisation procedures.
  • Alternative therapies are being investigated for their potential role in managing ischaemic heart disease.
  • Transmyocardial laser revascularisation (TMLR) is highlighted as a specific alternative treatment option.

Implications:

  • Understanding the spectrum of treatments for angina pectoris can guide clinical decision-making.
  • Further research into alternative therapies like TMLR may offer new avenues for patients refractory to conventional treatments.
  • Optimizing treatment strategies can alleviate symptoms, improve quality of life, and reduce mortality associated with ischaemic heart disease.

Related Concept Videos